The new formulation uses a bi-layer tablet delivery system, which controls the release of the pseudoephedrine component for consistent delivery. The recommended twice-daily dosing of the drug will help patients control their nasal congestion, along with their sneezing, runny nose, itchy throat, or itchy and watery eyes.
The extended release tablets are indicated for use in patients 12 years of age or older. The company said that the new formulation of the drug will be made available for patients in the US in March of this year, in time for the spring allergy season.
“For my patients who report nasal congestion along with other allergy symptoms, an antihistamine and decongestant combination treatment provides safe and effective relief,” said Dr William Lumry, Allergy & Asthma Specialists, Dallas, Texas.